• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于深度学习对多发性骨髓瘤苏木精-伊红染色样本中t(11;14)的预测

Deep-Learning-Based Prediction of t(11;14) in Multiple Myeloma H&E-Stained Samples.

作者信息

Kerner Nadav, Hershkovitz Dov, Trestman Svetlana, Shragai Tamir, Nachmias Hila Lederman, Cohen Yael C, Ziv-Baran Tomer, Avivi Irit

机构信息

Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Pathology Department, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.

出版信息

Cancers (Basel). 2025 May 22;17(11):1733. doi: 10.3390/cancers17111733.

DOI:10.3390/cancers17111733
PMID:40507215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12153534/
Abstract

BACKGROUND

Translocation of chromosomes 11 and 14 [t(11;14)(q13;32)] is the most common primary translocation in multiple myeloma (MM). Patients harboring t(11;14) exhibit high response rates to BCL-2 inhibitors, underscoring the importance of rapid detection to guide treatment decisions. While fluorescence in situ hybridization (FISH) remains the gold standard for detecting this abnormality, its application is limited by challenges related to speed, accessibility, and cost.

OBJECTIVES AND METHODS

This study evaluated a deep-learning-based method for detecting t(11;14) using scans of H&E-stained bone marrow biopsies from 268 untreated MM patients (147 males and 121 females).

RESULTS

Among these patients, 47 (17.5%) were diagnosed with smoldering MM, while 218 (81.4%) had active MM, including 22 (8.2%) that presented with concomitant amyloidosis. FISH analysis detected cytogenetic abnormalities in 191 cases (71%), with t(11;14) identified in 73 cases (27%) and a median of 26% positive cells in t(11;14)-positive cases. The AI algorithm achieved 88% sensitivity, 83.1% specificity, 84.3% accuracy, and an area under the receiver operating characteristic curve (AUROC) of 0.85 in conclusive results. The algorithm's performance was positively influenced by a higher percentage of plasma cells in the bone marrow ( < 0.001), active versus smoldering MM ( = 0.009), the presence of lytic lesions ( = 0.023), and lower hemoglobin levels ( = 0.025).

CONCLUSIONS

These findings suggest that this AI approach could facilitate rapid screening for FISH analysis, although further enhancements are necessary for its clinical application in MM management.

摘要

背景

11号和14号染色体易位[t(11;14)(q13;32)]是多发性骨髓瘤(MM)最常见的原发性易位。携带t(11;14)的患者对BCL-2抑制剂表现出高反应率,这突出了快速检测以指导治疗决策的重要性。虽然荧光原位杂交(FISH)仍然是检测这种异常的金标准,但其应用受到与速度、可及性和成本相关的挑战的限制。

目的和方法

本研究评估了一种基于深度学习的方法,该方法使用来自268例未经治疗的MM患者(147例男性和121例女性)的苏木精-伊红(H&E)染色骨髓活检扫描来检测t(11;14)。

结果

在这些患者中,47例(17.5%)被诊断为冒烟型MM,而218例(81.4%)患有活动性MM,其中22例(8.2%)伴有淀粉样变性。FISH分析在191例(71%)中检测到细胞遗传学异常,73例(27%)中鉴定出t(11;14),t(11;14)阳性病例中阳性细胞的中位数为26%。在确定性结果中,人工智能算法的灵敏度为88%,特异性为83.1%,准确率为84.3%,受试者操作特征曲线下面积(AUROC)为0.85。骨髓中浆细胞百分比更高(<0.001)、活动性MM与冒烟型MM(=0.009)、存在溶骨性病变(=0.023)以及血红蛋白水平较低(=0.025)对该算法的性能有积极影响。

结论

这些发现表明,这种人工智能方法有助于快速筛查FISH分析,但在MM管理中的临床应用还需要进一步改进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1dc/12153534/b46b360bd487/cancers-17-01733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1dc/12153534/b46b360bd487/cancers-17-01733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1dc/12153534/b46b360bd487/cancers-17-01733-g001.jpg

相似文献

1
Deep-Learning-Based Prediction of t(11;14) in Multiple Myeloma H&E-Stained Samples.基于深度学习对多发性骨髓瘤苏木精-伊红染色样本中t(11;14)的预测
Cancers (Basel). 2025 May 22;17(11):1733. doi: 10.3390/cancers17111733.
2
A deep learning algorithm for detecting lytic bone lesions of multiple myeloma on CT.一种用于在 CT 上检测多发性骨髓瘤溶骨性骨病变的深度学习算法。
Skeletal Radiol. 2023 Jan;52(1):91-98. doi: 10.1007/s00256-022-04160-z. Epub 2022 Aug 18.
3
[Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia].CD138磁珠分选荧光原位杂交技术在浆细胞肿瘤基因诊断中的应用价值
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Oct;24(5):1437-1442. doi: 10.7534/j.issn.1009-2137.2016.05.028.
4
Whole-body low-dose computed tomography in patients with newly diagnosed multiple myeloma predicts cytogenetic risk: a deep learning radiogenomics study.新诊断多发性骨髓瘤患者的全身低剂量计算机断层扫描可预测细胞遗传学风险:一项深度学习放射基因组学研究
Skeletal Radiol. 2025 Feb;54(2):267-273. doi: 10.1007/s00256-024-04733-0. Epub 2024 Jun 27.
5
The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma.t(11;14)(q13;q32)易位作为髓外浆细胞瘤骨髓瘤患者自体干细胞移植的不良预后参数。
Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):227-35. doi: 10.1016/j.clml.2014.12.007. Epub 2014 Dec 12.
6
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.浆细胞异常增生中缺失 13 获得的时间取决于遗传背景。
Haematologica. 2009 Dec;94(12):1708-13. doi: 10.3324/haematol.2009.011064.
7
Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study.多民族多发性骨髓瘤患者中的11号与14号染色体易位t(11;14)(q13;q32)及基因组失衡:一项马来西亚的研究
Hematol Rep. 2012 Jul 11;4(3):e19. doi: 10.4081/hr.2012.e19. Epub 2012 Sep 28.
8
[Cytoplasmic light-chain immunofluorescence combined with FISH in bone marrow smears to detect cytogenetic abnormalities in multiple myeloma].[骨髓涂片细胞质轻链免疫荧光联合荧光原位杂交检测多发性骨髓瘤细胞遗传学异常]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):566-570. doi: 10.3760/cma.j.cn121090-20231204-00291.
9
[Detection of Molecular Cytogenetic Aberrations by Fluorescence in Situ Hybridization in Different Bone Marrow Samples of Multiple Myeloma].[荧光原位杂交技术检测多发性骨髓瘤不同骨髓样本中的分子细胞遗传学异常]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Oct;23(5):1352-6. doi: 10.7534/j.issn.1009-2137.2015.05.024.
10
[Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].CD138免疫磁珠分选骨髓瘤细胞联合荧光原位杂交技术在检测多发性骨髓瘤细胞遗传学异常中的应用
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Jun;25(3):807-812. doi: 10.7534/j.issn.1009-2137.2017.03.031.

本文引用的文献

1
Exposure-response relationships of venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory t(11;14) multiple myeloma patients.维奈托克联合卡非佐米和地塞米松在复发/难治性t(11;14)多发性骨髓瘤患者中的暴露-反应关系。
Invest New Drugs. 2024 Dec;42(6):635-643. doi: 10.1007/s10637-024-01471-x. Epub 2024 Oct 10.
2
Deep learning for rapid virtual H&E staining of label-free glioma tissue from hyperspectral images.深度学习用于快速对无标记脑胶质瘤组织的高光谱图像进行虚拟 H&E 染色。
Comput Biol Med. 2024 Sep;180:108958. doi: 10.1016/j.compbiomed.2024.108958. Epub 2024 Aug 1.
3
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management.
多发性骨髓瘤:2024 年关于诊断、风险分层和治疗的更新。
Am J Hematol. 2024 Sep;99(9):1802-1824. doi: 10.1002/ajh.27422. Epub 2024 Jun 28.
4
Enhancing diagnostic accuracy of multiple myeloma through ML-driven analysis of hematological slides: new dataset and identification model to support hematologists.通过机器学习驱动的血液学幻灯片分析提高多发性骨髓瘤的诊断准确性:支持血液学家的新数据集和识别模型。
Sci Rep. 2024 May 15;14(1):11176. doi: 10.1038/s41598-024-61420-9.
5
New diagnostic strategy for multiple myeloma: A review.多发性骨髓瘤的新诊断策略:综述。
Medicine (Baltimore). 2023 Dec 29;102(52):e36660. doi: 10.1097/MD.0000000000036660.
6
Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies.深度学习实现多发性骨髓瘤骨髓活检组织镶嵌微环境的空间映射。
Cancer Res. 2024 Feb 1;84(3):493-508. doi: 10.1158/0008-5472.CAN-22-2654.
7
Image-Based Deep Learning Detection of High-Grade B-Cell Lymphomas Directly from Hematoxylin and Eosin Images.基于图像的深度学习直接从苏木精和伊红图像中检测高级别B细胞淋巴瘤
Cancers (Basel). 2023 Oct 29;15(21):5205. doi: 10.3390/cancers15215205.
8
Artificial intelligence and digital pathology: clinical promise and deployment considerations.人工智能与数字病理学:临床前景与应用考量
J Med Imaging (Bellingham). 2023 Sep;10(5):051802. doi: 10.1117/1.JMI.10.5.051802. Epub 2023 Jul 31.
9
Applied machine learning in hematopathology.应用机器学习在血液病理学中的应用。
Int J Lab Hematol. 2023 Jun;45 Suppl 2:87-94. doi: 10.1111/ijlh.14110. Epub 2023 May 31.
10
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology.人工智能在组织病理学中的应用:增强癌症研究和临床肿瘤学。
Nat Cancer. 2022 Sep;3(9):1026-1038. doi: 10.1038/s43018-022-00436-4. Epub 2022 Sep 22.